Los registros los proporcionan patrocinadores e investigadores. Estar en el registro no garantiza seguridad, disponibilidad ni elegibilidad, ni representa un aval. Los títulos, resúmenes y criterios originales del registro se muestran en inglés para conservar su significado.
Listado de WCR consultado: 11 nov 2026.
ReclutandoNCT06818643
Advanced Solid Tumors · Malignant Neoplasm
Fase 1 / Fase 218 años - No especificadoMiami, Florida, United States +40 Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumors are cancers mostly in body organs and tissues, n…
ReclutandoNCT07645287
HIV-1-infection
Fase 218 años - No especificadoMiami, Florida, United States +53 The study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS-3242 plus Lenacapavir (LEN) versus continuing Biktarvy (bictegravir/emtricitabine/tenofovir alafenam…
ReclutandoNCT03618550
Hodgkin Lymphoma · Relapsed or Refractory Hodgkin Lymphoma
Fase 218 años - No especificadoMiami, Florida, United States +9 The purpose of this study is to test any good and bad effects of the study drug, pembrolizumab, in combination with GVD in the treatment of Hodgkin lymphoma.
ReclutandoNCT07099898
Neoplasms, Lung
Fase 318 años - No especificadoMiami, Florida, United States +127 In this study researchers are testing Risvutatug rezetecan also known as (Ris-Rez) a new medicine that targets specific proteins (B7-H3) on cancer cells, thereby reducing the cancer's ability to grow and spread. This study specifically aims to evalua…
ReclutandoNCT07357727
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Fase 318 años - No especificadoMiami, Florida, United States +159 The purpose of this trial is to evaluate whether treatment with pelabresib in combination with ruxolitinib leads to improved clinical outcomes compared to ruxolitinib alone in patients with primary myelofibrosis (PMF), post-polycythemia vera myelofib…
ReclutandoNCT07430306
Systemic Lupus Erythematosus
Fase 318 años - 70 añosMiami, Florida, United States +88 The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti-malarial, with or without GC; in patients not in …
ReclutandoNCT07929792
Spinal Cord Injury · Amyotrophic Lateral Sclerosis · Chronic Ischemic Stroke · Tetraplegia/Tetraparesis
No aplica18 años - No especificadoMiami, Florida, United States The purpose of this study is to evaluate the safety and preliminary effectiveness of the N1 System, a fully implanted brain-computer interface placed in the motor cortex with the R1 Robot. The study builds on knowledge gained in a previous clinical i…
ReclutandoNCT06806033
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Fase 218 años - No especificadoMiami, Florida, United States +49 This Phase II trial evaluates the optimization of the cytokine release syndrome (CRS) profile for glofitamab in combination with gemcitabine and oxaliplatin (Glofit-GemOx) followed by glofitamab monotherapy treatment regimen (Cohort A), and for glofitam…
ReclutandoNCT07235059
Chronic Kidney Disease
Fase 118 años - 65 añosMiami, Florida, United States +1 The purpose of this first-in-human (FIH) study is to evaluate safety, tolerability, pharmacokinetic (PK) of OJR520.
ReclutandoNCT01209000
Minimal Change Disease (MCD) · Membranous Nephropathy · Glomerulosclerosis, Focal Segmental
ObservacionalNo especificado - 80 añosMiami, Florida, United States +31 Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting for approximately 12% of prevalent end stage renal disease (ESRD) case…
ReclutandoNCT06430801
Crohn's Disease
Fase 316 años - 80 añosMiami, Florida, United States +402 The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in…
ReclutandoNCT07650916
HIV
Fase 312 años - No especificadoMiami, Florida, United States +83 This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).
Consultado en ClinicalTrials.gov: 11 nov 2026. El estado general puede ser distinto al de un centro específico.
